EDGAR Filing Documents for 0000950123-09-063131

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000950123-09-063131

Filing Date

2009-11-16

Accepted

2009-11-16 17:00:35

Documents

Period of Report

2009-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	RXI PHARMACEUTICALS, INC.	b77496e10vq.htm	10-Q	185775
2	EX-10.2 PATENT AND TECHNOLOGY ASSIGNMENT AGREEMENT BETWEEN RXI PHARMACEUTICALS C	b77496exv10w2.htm	EX-10.2	95302
3	EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER	b77496exv31w1.htm	EX-31.1	8183
4	EX-31.2 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER	b77496exv31w2.htm	EX-31.2	8451
5	EX-32.1 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL	b77496exv32w1.htm	EX-32.1	3663
	Complete submission text file	0000950123-09-063131.txt		302705

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605

Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861

RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 091187851
SIC: 2834 Pharmaceutical Preparations